Skip to main content
Equibles
IRON logo

IRON · Disc Medicine, Inc. · Metrics

Track IRON — free

Use IRON with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IRON.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$81.16 +2.54 (+3.23%) At close · Nov 3
Russell 2000 member Rebalance outlook locked
Market Cap
$3.02B
Shares
38.39M
Volume · Nov 3 1.54M Avg daily vol (3M) 835.19K

IRON metrics

69 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$81.16
Market cap
$3.02B

Price action

20 metrics
Price change (1W)
+1.2%
Price change (30D)
+24.1%
Price change (3M)
+3.0%
Price change (6M)
+16.2%
Price change (YTD)
-1.0%
Price change (1Y)
-8.8%
Trailing year
Price change (5Y)
—
52-week high
$94.11
52-week low
$55.74
Change from 52-week high
-16.5%
Change from 52-week low
+41.0%
Annualized volatility
63.0%
Annualized volatility (3M)
85.0%
Beta
0.9
RSI (14D)
60.3
Price vs SMA 50
+10.2%
Price vs SMA 200
+11.2%
Avg volume (3M)
815,965
Relative volume
0.6
Average dollar volume
$60.32M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
38.39M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
4.7
reciprocal yield 21.3%
FCF yield
-6.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-8.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-19

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$269.26M
Net income (TTM)
−$245.89M
Trailing 12 months
Diluted EPS (TTM)
$-6.60
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-7.19
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-6.57
Operating cash flow per diluted share (TTM)
$-5.27
Free cash flow per diluted share (TTM)
$-5.27
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
$5.07
Stock compensation per diluted share (TTM)
$1.21
Book value per share
$19.53

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+10.5%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-38.2%
Return on assets
-33.5%
Debt / equity
0.1
Current ratio
24.1
EBITDA (TTM)
—
Free cash flow (TTM)
−$197.58M
Quick ratio
24.1
Interest coverage
-75.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$658.41M
Latest balance sheet
Cash & equivalents
$98.68M
Total assets
$735.07M
Total debt
$59.34M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$197.54M
Capital expenditures (TTM)
$46,000
R&D (TTM)
$189.40M
SG&A (TTM)
$79.87M
Stock compensation (TTM)
$45.45M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
224
13F filer change QoQ
+16
Institutional ownership
112.5%
Conviction holders (share of 13F filers)
3.2%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+3.4%
Holder tenure
9.2
Price vs estimated holder cost
+16.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
13.5%

Short interest

3 metrics
Short interest
19.4%
Latest settlement · 10.6 days to cover
Days to cover
10.6d
Short-squeeze score
81 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$13.59M
Insider-sentiment score
29 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1816736 CUSIP 254604101 13F (30d) 50 filings 44 filers Visit website Investor relations